FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Nephro Care India IPO and Sati Poly Plast IPO.
Nephro Care India IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Sati Poly Plast IPO is a SME Book Built Issue proposed to list at NSE SME.
Nephro Care India IPO | Sati Poly Plast IPO | |
---|---|---|
Logo | ![]() |
![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Corporate Capitalventures Pvt Ltd | Beeline Capital Advisors Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Link Intime India Private Ltd |
Market Maker | Ss Corporate Securities Limited | Spread X Securities Private Limited |
DRHP | DRHP ![]() |
DRHP ![]() |
RHP | RHP ![]() |
RHP ![]() |
Anchor Investor | Anchor Investor ![]() |
|
IPO Allotment URL | IPO Allotment URL ![]() |
The total issue size of Nephro Care India IPO is up to ₹41.26 Cr whereas the issue size of the Sati Poly Plast IPO is up to ₹17.36 Cr. The final issue price of Nephro Care India IPO is ₹90.00 per share and of Sati Poly Plast IPO is .
Nephro Care India IPO | Sati Poly Plast IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹85.00 per share | ₹123.00 per share |
Issue Price (Upper) | ₹90.00 per share | ₹130.00 per share |
Issue Price (Final) | ₹90.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 1000 shares |
Fresh Issue Size | 45,84,000 shares | 13,35,000 shares |
Fresh Issue Size (Amount) | up to ₹41.26 Cr | up to ₹17.36 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 45,84,000 shares | 13,35,000 shares |
Issue Size Total (Amount) | up to ₹41.26 Cr | up to ₹17.36 Cr |
Nephro Care India IPO opens on Jun 28, 2024, while Sati Poly Plast IPO opens on Jul 12, 2024. The closing date of Nephro Care India IPO and Sati Poly Plast IPO is Jul 02, 2024, and Jul 16, 2024, respectively.
Nephro Care India IPO | Sati Poly Plast IPO | |
---|---|---|
Anchor Bid Date | Jun 27, 2024 | Jul 11, 2024 |
Issue Open | Jun 28, 2024 | Jul 12, 2024 |
Issue Close | Jul 02, 2024 | Jul 16, 2024 |
Basis Of Allotment (Tentative) | Jul 03, 2024 | Jul 18, 2024 |
Initiation of Refunds (Tentative) | Jul 04, 2024 | Jul 19, 2024 |
Credit of Share (Tentative) | Jul 04, 2024 | Jul 19, 2024 |
Listing date (Tentative) | Jul 05, 2024 | Jul 22, 2024 |
Anchor Lockin End date 1 | Aug 02, 2024 | Aug 17, 2024 |
Anchor Lockin End date 2 | Oct 01, 2024 | Oct 16, 2024 |
Nephro Care India IPO P/E ratio is 55.15, as compared to Sati Poly Plast IPO P/E ratio of 14.29.
Nephro Care India IPO | Sati Poly Plast IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Nephro Care India Limited Financial Information (Restated)Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Sati Poly Plast Limited Financial Information (Restated)Sati Poly Plast Limited's revenue decreased by -6.05% and profit after tax (PAT) rose by 6.39% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 85.02% | 86.30% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 61.39% | 63.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 55.15 | 14.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹148.38 Cr. | ₹64.31 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 41.57%% | 40.38%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 36.56%% | 20.45%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 1.82 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹1.63 | ₹9.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 24.42%% | 26.71%% |
In the Nephro Care India IPO retail investors (RII) are offered 14,44,800 shares while in Sati Poly Plast IPO retail investors are offered 14,44,800 shares. Qualified institutional buyers (QIB) are offered 8,25,600 shares in Nephro Care India IPO and in Sati Poly Plast IPO.
Nephro Care India IPO | Sati Poly Plast IPO | |
---|---|---|
Anchor Investor Reserveration | 12,38,400 shares | |
Market Maker Reserveration | 2,30,400 shares | 70,000 shares |
QIB | 8,25,600 shares | |
NII | 6,19,200 shares | |
RII | 14,44,800 shares | |
Employee | 0 shares | |
Others | ||
Total | 31,15,200 shares |
Nephro Care India IPO subscribed 715.78x in total, whereas Sati Poly Plast IPO subscribed .
Nephro Care India IPO | Sati Poly Plast IPO | |
---|---|---|
QIB (times) | 245.14x | |
NII (times) | 1,787.19x | |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 634.12x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 715.78x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|